Close X
Friday, November 15, 2024
ADVT 
International

US Mission in India processes over 1 mn non-immigrant visas in 2023

Darpan News Desk IANS, 28 Sep, 2023 10:48 AM
  • US Mission in India processes over 1 mn non-immigrant visas in 2023

New Delhi, Sep 28 (IANS): The US Mission to India said on Thursday that it has reached and surpassed its goal to process one million non-immigrant visa applications in 2023.

Stating that Indians made over one in 10 visa applications worldwide, the Mission said it has already surpassed the total number of cases processed in 2022 and is processing almost 20 per cent more applications than in pre-pandemic 2019.

“Our partnership with India is one of the United States’ most important bilateral relationships, and in fact one of the most important relationships in the world," US Ambassador to India Eric Garcetti said.

"The ties between our people are stronger than ever, and we will continue our record-setting volume of visa work in the coming months to give as many Indian applicants as possible the opportunity to travel to the United States and experience the US-India friendship firsthand,” Garcetti added.

The Ambassador on Thursday handed over the passport to the one millionth visa holder and said: “… this year we are so proud… we have processed over 1 million visa applications."

Last year ,over 1.2 million Indians visited the US, making this one of the most robust travel relationships in the world.

Indians now represent over 10 per cent of all visa applicants worldwide, including 20 per cent of all student visa applicants and 65 per cent of all H&L-category (employment) visa applicants.

Recognising the continued high demand for its visas, the Mission said that the US continues to invest heavily in our operations in India.

In the past year, the Mission said it expanded its staffing to facilitate more visa processing, and made significant capital improvements to existing facilities, such as the US Consulate in Chennai, and inaugurating a new Consulate building in Hyderabad.

The Mission said that beginning next year, it plans to implement a pilot program that would allow domestic visa renewal for qualified H&L-category employment visa applicants.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK